Jessica Sachs
CIK 1782545 · View on SEC EDGAR ↗
First SEC filing: July 17, 2019 · Latest: July 17, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2025 | COGT | S | 82,642 | $38.70 | $3,198,245 | 133,938 Direct | -38.16% | Disposed | -6.6% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | COGT | Stock Option (Right to Buy) | Common Stock (65,000) | $39.45 | Dec. 17, 2035 | 65,000 | Acquired |
| Jan. 23, 2025 | COGT | Stock Option (Right to Buy) | Common Stock (270,000) | $8.89 | Jan. 23, 2035 | 270,000 | Acquired |
| Jan. 23, 2024 | COGT | Stock Option (Right to Buy) | Common Stock (300,000) | $4.63 | Jan. 23, 2034 | 300,000 | Acquired |
| Feb. 13, 2023 | COGT | Stock Option (Right to Buy) | Common Stock (160,000) | $13.63 | Feb. 13, 2033 | 160,000 | Acquired |
| Jan. 25, 2022 | COGT | Stock Option (Right to Buy) | Common Stock (250,000) | $7.60 | Jan. 25, 2032 | 250,000 | Acquired |
| Feb. 10, 2021 | COGT | Stock Option (Right to Buy) | Common Stock (126,500) | $10.17 | Feb. 10, 2031 | 126,500 | Acquired |
| Feb. 1, 2021 | COGT | Stock Option (Right to Buy) | Common Stock (400,000) | $9.10 | Feb. 1, 2031 | 400,000 | Acquired |
| Feb. 11, 2020 | COGT | Stock Option | Common Stock (133,200) | $0.80 | Feb. 11, 2030 | 133,200 | Acquired |
| July 19, 2019 | COGT | Stock Option (Right to Buy) | Common Stock (123,800) | $2.61 | July 19, 2029 | 123,800 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 5 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 17, 2019 | COGT | Stock Option (Right to Buy)→ Common Stock (63,688) | 63,688 | Direct |
| July 17, 2019 | COGT | Stock Option (Right to Buy)→ Common Stock (12,737) | 12,737 | Direct |
| July 17, 2019 | COGT | Stock Option (Right to Buy)→ Common Stock (21,017) | 21,017 | Direct |
| July 17, 2019 | COGT | Stock Option (Right to Buy)→ Common Stock (21,017) | 21,017 | Direct |
| July 17, 2019 | COGT | Stock Option (Right to Buy)→ Common Stock (22,419) | 22,419 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
COGT
Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $527,436 | — | — | — | $272,948 | — | $13,800 | $1,832,714 |
| 2023 | $507,150 | $253,575 | — | — | — | — | $13,200 | $2,999,941 |
| 2022 | $482,558 | $177,744 | — | — | — | — | $12,200 | $1,907,927 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.